Previous Close | 1.0000 |
Open | 0.9900 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.9800 - 1.0000 |
52 Week Range | 0.5310 - 2.3500 |
Volume | |
Avg. Volume | 31,350 |
Market Cap | 23.987M |
Beta (5Y Monthly) | 0.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6000 |
Earnings Date | Aug 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.69 |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Company expands relationship with manufacturing partner Medical Murray, and continues active exploration of standalone opportunities for RenovoCath RenovoCath Image RenovoCath Image LOS ALTOS, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies based on a local drug-delivery platform, today announced that it is increasing the production of its FDA-cleared RenovoCath catheter-b